Compare $CLDI vs $DCOY | Chartloom

Compare

$CLDI vs $DCOY

Calidi Biotherapeutics Inc · Decoy Therapeutics Inc

CLDI

Calidi Biotherapeutics Inc

DCOY

Decoy Therapeutics Inc

Compare $CLDI vs $DCOY

Comparing Calidi Biotherapeutics Inc and Decoy Therapeutics Inc

CLDICalidi Biotherapeutics Inc

DCOYDecoy Therapeutics Inc

CLDICalidi Biotherapeutics Inc

Market cap

$20M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-94.5%

52W performance

-96.0%

FCF yield

-89.7%

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLDI

DCOY

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

DCOY

Decoy Therapeutics Inc

Market Cap

CLDI$20M

DCOY$779K

Enterprise Value

CLDI$17M

DCOY$-8M

Price

CLDI$1.03

DCOY$1.47

P/E Ratio

CLDIN/A

DCOYN/A

P/S Ratio

CLDI0.00x

DCOY3.42x

EV/Sales

CLDI0.00x

DCOY-33.00x

EV/EBITDA

CLDI0.00x

DCOY0.00x

P/B Ratio

CLDI1.27x

DCOY0.75x

P/FCF Ratio

CLDIN/A

DCOYN/A

EV/FCF

CLDI-0.94x

DCOY0.90x

PEG Ratio

CLDIN/A

DCOYN/A

Forward P/E (NTM)

CLDIN/A

DCOYN/A

Forward P/S (NTM)

CLDIN/A

DCOYN/A

Revenue (TTM)

CLDI$0

DCOY$228K

Revenue Growth (YoY)

CLDIN/A

DCOYN/A

Forward Rev Growth

CLDI0.0%

DCOY0.0%

Gross Margin (TTM)

CLDI0.0%

DCOY48.6%

Operating Margin (TTM)

CLDI0.0%

DCOY0.0%

EBITDA Margin (TTM)

CLDI0.0%

DCOY-2668.9%

Net Margin (TTM)

CLDI0.0%

DCOY-6348.7%

FCF Margin (TTM)

CLDIN/A

DCOY-3676.1%

Net Income (TTM)

CLDI$-23M

DCOY$-14M

FCF (TTM)

CLDI$-18M

DCOY$-8M

EPS (TTM)

CLDI-$265.03

DCOY-$27.16

ROE (TTM)

CLDI-37285.0%

DCOY-31523.0%

ROA (TTM)

CLDI-17613.0%

DCOY-16715.0%

ROIC (TTM)

CLDI-30694.0%

DCOY-31523.0%

Cash

CLDI$4M

DCOY$8M

Debt

CLDI$928K

DCOY$0

Net Cash/Debt

CLDI$3M

DCOY$8M

Current Ratio (TTM)

CLDI1.68x

DCOY1.83x

Quick Ratio (TTM)

CLDI1.55x

DCOY1.77x

Debt/Equity (TTM)

CLDI0.30x

DCOY0.00x

Debt/Assets (TTM)

CLDI0.0%

DCOY0.0%

Interest Coverage (TTM)

CLDIN/A

DCOYN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

DCOY0.00x

Beta

CLDI1.37

DCOY0.68

52W Performance

CLDI-96.0%

DCOY-97.0%

YTD Performance

CLDI-94.5%

DCOY-81.2%

% from 52W High

CLDI-96.3%

DCOY-97.4%

% from 52W Low

CLDI4.5%

DCOY0.7%

Asset Turnover (TTM)

CLDI0.00x

DCOY0.03x

FCF Yield (TTM)

CLDI-89.7%

DCOY-1073.9%

Earnings Yield (TTM)

CLDI-117.9%

DCOY-1854.7%

Dividend Yield (TTM)

CLDIN/A

DCOYN/A

Rule of 40

CLDI0.0

DCOY-3,676.1

EV/GP/RG

CLDIN/A

DCOYN/A

Ticker research

View CLDI research View DCOY research

Metric	CLDI Calidi Biotherapeutics Inc	DCOY Decoy Therapeutics Inc
Market & Valuation
Market Cap	$20M	$779K
Enterprise Value	$17M	$-8M
Price	$1.03	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.42x
EV/Sales	0.00x	-33.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$228K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	48.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2668.9%
Net Margin (TTM)	0.0%	-6348.7%
FCF Margin (TTM)	N/A	-3676.1%
Net Income (TTM)	$-23M	$-14M
FCF (TTM)	$-18M	$-8M
EPS (TTM)	-$265.03	-$27.16
ROE (TTM)	-37285.0%	-31523.0%
ROA (TTM)	-17613.0%	-16715.0%
ROIC (TTM)	-30694.0%	-31523.0%
Financial Health
Cash	$4M	$8M
Debt	$928K	$0
Net Cash/Debt	$3M	$8M
Current Ratio (TTM)	1.68x	1.83x
Quick Ratio (TTM)	1.55x	1.77x
Debt/Equity (TTM)	0.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.68
52W Performance	-96.0%	-97.0%
YTD Performance	-94.5%	-81.2%
% from 52W High	-96.3%	-97.4%
% from 52W Low	4.5%	0.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.03x
FCF Yield (TTM)	-89.7%	-1073.9%
Earnings Yield (TTM)	-117.9%	-1854.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,676.1
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View DCOY research

Valuation

P/S Ratio

CLDI

0.00x

DCOY

3.42x

EV/FCF

CLDI

-0.94x

DCOY

0.90x

Growth & revenue

Forward Revenue Growth

CLDI

0.0%

DCOY

0.0%

Profitability & performance

Gross Margin

DCOY

48.6%

CLDI

0.0%

ROE

DCOY

-31523.0%

CLDI

-37285.0%

FCF Yield %

CLDI

-89.7%

DCOY

-1073.9%

52-Week Performance

CLDI

-96.0%

DCOY

-97.0%

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

DCOY

Decoy Therapeutics Inc

Market Cap

CLDI$20M

DCOY$779K

Enterprise Value

CLDI$17M

DCOY$-8M

Price

CLDI$1.03

DCOY$1.47

P/E Ratio

CLDIN/A

DCOYN/A

P/S Ratio

CLDI0.00x

DCOY3.42x

EV/Sales

CLDI0.00x

DCOY-33.00x

EV/EBITDA

CLDI0.00x

DCOY0.00x

P/B Ratio

CLDI1.27x

DCOY0.75x

P/FCF Ratio

CLDIN/A

DCOYN/A

EV/FCF

CLDI-0.94x

DCOY0.90x

PEG Ratio

CLDIN/A

DCOYN/A

Forward P/E (NTM)

CLDIN/A

DCOYN/A

Forward P/S (NTM)

CLDIN/A

DCOYN/A

Revenue (TTM)

CLDI$0

DCOY$228K

Revenue Growth (YoY)

CLDIN/A

DCOYN/A

Forward Rev Growth

CLDI0.0%

DCOY0.0%

Gross Margin (TTM)

CLDI0.0%

DCOY48.6%

Operating Margin (TTM)

CLDI0.0%

DCOY0.0%

EBITDA Margin (TTM)

CLDI0.0%

DCOY-2668.9%

Net Margin (TTM)

CLDI0.0%

DCOY-6348.7%

FCF Margin (TTM)

CLDIN/A

DCOY-3676.1%

Net Income (TTM)

CLDI$-23M

DCOY$-14M

FCF (TTM)

CLDI$-18M

DCOY$-8M

EPS (TTM)

CLDI-$265.03

DCOY-$27.16

ROE (TTM)

CLDI-37285.0%

DCOY-31523.0%

ROA (TTM)

CLDI-17613.0%

DCOY-16715.0%

ROIC (TTM)

CLDI-30694.0%

DCOY-31523.0%

Cash

CLDI$4M

DCOY$8M

Debt

CLDI$928K

DCOY$0

Net Cash/Debt

CLDI$3M

DCOY$8M

Current Ratio (TTM)

CLDI1.68x

DCOY1.83x

Quick Ratio (TTM)

CLDI1.55x

DCOY1.77x

Debt/Equity (TTM)

CLDI0.30x

DCOY0.00x

Debt/Assets (TTM)

CLDI0.0%

DCOY0.0%

Interest Coverage (TTM)

CLDIN/A

DCOYN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

DCOY0.00x

Beta

CLDI1.37

DCOY0.68

52W Performance

CLDI-96.0%

DCOY-97.0%

YTD Performance

CLDI-94.5%

DCOY-81.2%

% from 52W High

CLDI-96.3%

DCOY-97.4%

% from 52W Low

CLDI4.5%

DCOY0.7%

Asset Turnover (TTM)

CLDI0.00x

DCOY0.03x

FCF Yield (TTM)

CLDI-89.7%

DCOY-1073.9%

Earnings Yield (TTM)

CLDI-117.9%

DCOY-1854.7%

Dividend Yield (TTM)

CLDIN/A

DCOYN/A

Rule of 40

CLDI0.0

DCOY-3,676.1

EV/GP/RG

CLDIN/A

DCOYN/A

Ticker research

View CLDI research View DCOY research

Metric	CLDI Calidi Biotherapeutics Inc	DCOY Decoy Therapeutics Inc
Market & Valuation
Market Cap	$20M	$779K
Enterprise Value	$17M	$-8M
Price	$1.03	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.42x
EV/Sales	0.00x	-33.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$228K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	48.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2668.9%
Net Margin (TTM)	0.0%	-6348.7%
FCF Margin (TTM)	N/A	-3676.1%
Net Income (TTM)	$-23M	$-14M
FCF (TTM)	$-18M	$-8M
EPS (TTM)	-$265.03	-$27.16
ROE (TTM)	-37285.0%	-31523.0%
ROA (TTM)	-17613.0%	-16715.0%
ROIC (TTM)	-30694.0%	-31523.0%
Financial Health
Cash	$4M	$8M
Debt	$928K	$0
Net Cash/Debt	$3M	$8M
Current Ratio (TTM)	1.68x	1.83x
Quick Ratio (TTM)	1.55x	1.77x
Debt/Equity (TTM)	0.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.68
52W Performance	-96.0%	-97.0%
YTD Performance	-94.5%	-81.2%
% from 52W High	-96.3%	-97.4%
% from 52W Low	4.5%	0.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.03x
FCF Yield (TTM)	-89.7%	-1073.9%
Earnings Yield (TTM)	-117.9%	-1854.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,676.1
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View DCOY research